Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LE.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.36NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.49.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.3.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LB.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GE.1.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.58.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used